Article Versions Notes

Larrinaga G, Solano-Iturri JD, Arrieta-Aguirre I, Valdivia A, Lecumberri D, Iturregui AM, Lawrie CH, Armesto M, Dorado JF, Nunes-Xavier CE, et al. Prognostic and Therapeutic Implications of Alamandine Receptor MrgD Expression in Clear Cell Renal Cell Carcinoma with Development of Metastatic Disease. Biomolecules. 2025; 15(3):387. https://doi.org/10.3390/biom15030387

Larrinaga, Gorka, Jon Danel Solano-Iturri, Inés Arrieta-Aguirre, Asier Valdivia, David Lecumberri, Ane Miren Iturregui, Charles H. Lawrie, María Armesto, Juan F. Dorado, Caroline E. Nunes-Xavier, and et al. 2025. "Prognostic and Therapeutic Implications of Alamandine Receptor MrgD Expression in Clear Cell Renal Cell Carcinoma with Development of Metastatic Disease" Biomolecules 15, no. 3: 387. https://doi.org/10.3390/biom15030387

Larrinaga, G., Solano-Iturri, J. D., Arrieta-Aguirre, I., Valdivia, A., Lecumberri, D., Iturregui, A. M., Lawrie, C. H., Armesto, M., Dorado, J. F., Nunes-Xavier, C. E., Pulido, R., López, J. I., & Angulo, J. C. (2025). Prognostic and Therapeutic Implications of Alamandine Receptor MrgD Expression in Clear Cell Renal Cell Carcinoma with Development of Metastatic Disease. Biomolecules, 15(3), 387. https://doi.org/10.3390/biom15030387